Allied Corp Teams Up With Switzerland Based Company To Offer GMP Certified Medical Cannabis

Comments
Loading...

Allied Corp. ALID has signed an agreement with a GMP certified partner in Switzerland that will enable Allied to be able to offer products with the good manufacturing practices approved certifications.

Allied has entered into an agreement with a company that holds a Swiss Medic narcotics and processing license that will enable Allied’s Colombian produced medical cannabis to be offered into countries that require GMP certified products.

Allied’s clients and supply channel partners span five world continents that include Australia, Europe, Asia, South America and North America. Allied's relationships with international partners are based on sustainable, long-term agreements that were designed with the Allied Inside supply chain in mind.

“We are proud to say that our Colombian production has now met vendor qualification approval for several vendors. Given that we are now able to offer GMP products opens many additional commercial relationships and markets.” stated Calum Hughes, CEO and chairman of the board.

Photo: Benzinga edit with photos by Matthias Zomer on Pexels, squarefrog on Pixabay

Related News

Allied Corp Teams Up With Blueberries Medical To Produce Psychoactive And Non-Psychoactive Derivatives

Allied Corp's First THC Flower Harvests Now Offered For Sale And Export From Colombia

Allied Corp Ships Second Commercial Cannabis Flower Export From Colombia To International Market

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.